MediciNova, Inc. (MNOV) Social Stream



MediciNova, Inc. (MNOV): $2.13

0.03 (+1.43%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add MNOV to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#185 of 402

in industry

MEDICINOVA INC (MNOV) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering MEDICINOVA INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-30 3 $27 $10 $16.5 $2.09 689.47%
2022-03-01 3 $27 $6 $14.333 $2.09 585.79%
2022-04-06 1 $27 $6 $14.333 $2.09 585.79%
2022-08-19 2 $27 $6 $13 $2.09 522.01%
2023-02-27 3 $27 $6 $13 $2.09 522.01%
2023-05-30 2 $27 $6 $16.5 $2.09 689.47%
2023-08-21 2 $26 $6 $16 $2.09 665.55%

The Trend in the Analyst Price Target


Over the past 25 months, MNOV's average price target has gone down $2.

MNOV reports an average of 561.93% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-27 2 27 6 16.5 2.21 646.61%
2023-02-27 3 27 6 13.0 2.21 488.24%
2023-02-27 3 27 6 16.5 2.21 646.61%
2023-08-21 2 26 6 16.0 2.36 577.97%
2023-08-21 1 26 6 16.0 2.36 577.97%

MNOV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


MNOV's average broker recommendation rating improved by 0 over the prior 15 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MNOV as an investment opportunity.

  • MNOV has a greater number of analysts covering the stock than 43.96% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, MEDICINOVA INC's upside potential (average analyst target price relative to current price) is greater than 1036.06% of them.
  • To contextualize these metrics, consider that out of all US stocks, MEDICINOVA INC's variance in analysts' estimates is lower than -934.83% of them.
  • MEDICINOVA INC's average analyst price target is greater than 295.72% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MEDICINOVA INC are SVRA, BPTH, and ONTX.

Is MNOV a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!